{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:07:57Z","timestamp":1793387277317,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jmii.2019.09.002","type":"journal-article","created":{"date-parts":[[2019,11,28]],"date-time":"2019-11-28T20:14:31Z","timestamp":1574972071000},"page":"542-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7262-861X","authenticated-orcid":false,"given":"Chun-Han","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ying","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Tsung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hsien","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Kai","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Jen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Jong","family":"Bair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2019.09.002_bib1","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/j.gastro.2011.06.007","article-title":"Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial","volume":"141","author":"Hoefs","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jmii.2019.09.002_bib2","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jmii.2019.09.002_bib3","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/hep.510230522","article-title":"The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy","volume":"23","author":"Lindor","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2019.09.002_bib4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1440-1746.2010.06385.x","article-title":"The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: a multicenter, prospective study","volume":"26","author":"Kim","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jmii.2019.09.002_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.21972","article-title":"Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications","volume":"47","author":"Talwalkar","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2019.09.002_bib6","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3350\/cmh.2013.19.2.156","article-title":"The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis","volume":"19","author":"Chung","year":"2013","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jmii.2019.09.002_bib7","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2019.09.002_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/hep.21669","article-title":"FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotest","volume":"46","author":"Vallet-Pichard","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2019.09.002_bib9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2019.09.002_bib10","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0016-5085(88)80022-2","article-title":"Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis","volume":"95","author":"Williams","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jmii.2019.09.002_bib11","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1053\/jhep.2002.36128","article-title":"Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model","volume":"36","author":"Forns","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2019.09.002_bib12","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2019.09.002_bib13","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/MCG.0000000000000215","article-title":"Prospective comparison of noninvasive fibrosis assessment to predict advanced fibrosis or cirrhosis in Asian patients with hepatitis C","volume":"49","author":"Joo","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jmii.2019.09.002_bib14","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/hep.24105","article-title":"Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis","volume":"53","author":"Lin","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2019.09.002_bib15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/cid\/cit245","article-title":"Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort","volume":"57","author":"Holmberg","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2019.09.002_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3748\/wjg.v11.i2.255","article-title":"Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease","volume":"11","author":"Sakugawa","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jmii.2019.09.002_bib17","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2019.09.002_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2001.25540","article-title":"Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese","volume":"121","author":"Dixon","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jmii.2019.09.002_bib19","doi-asserted-by":"crossref","first-page":"e0155967","DOI":"10.1371\/journal.pone.0155967","article-title":"Serological tests do not predict residual fibrosis in hepatitis C cirrhotics with a sustained virological response to interferon","volume":"11","author":"D'Ambrosio","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2019.09.002_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejphar.2017.03.063","article-title":"Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: a preliminary study","volume":"806","author":"Stasi","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jmii.2019.09.002_bib21","doi-asserted-by":"crossref","first-page":"e0133515","DOI":"10.1371\/journal.pone.0133515","article-title":"Predictive ability of laboratory indices for liver fibrosis in patients with chronic hepatitis C after the eradication of hepatitis C virus","volume":"10","author":"Tachi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2019.09.002_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.12998\/wjcc.v6.i12.521","article-title":"Declining diagnostic accuracy of non-invasive fibrosis tests is associated with elevated alanine aminotransferase in chronic hepatitis B","volume":"6","author":"Wang","year":"2018","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.jmii.2019.09.002_bib23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","article-title":"EASL-ALEH Clinical Practice Guidelines: non-invasive tests for evaluation of liver disease severity and prognosis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.jmii.2019.09.002_bib24","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.3748\/wjg.v20.i11.2854","article-title":"Non-invasive diagnosis of liver fibrosis in chronic hepatitis C","volume":"20","author":"Schiavon Lde","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jmii.2019.09.002_bib25","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/00042737-200411000-00022","article-title":"Histological response in patients treated by\u00a0interferon plus ribavirin for hepatitis C virus-related severe fibrosis","volume":"16","author":"Abergel","year":"2004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jmii.2019.09.002_bib26","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C","volume":"122","author":"Poynard","year":"2002","journal-title":"Gastroenterology"},{"issue":"7","key":"10.1016\/j.jmii.2019.09.002_bib27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.jfma.2018.11.005","article-title":"Long-term histological change in chronic hepatitis C patients who had received peginterferon plus ribavirin therapy with sustained virological response","volume":"118","author":"Chu","year":"2019","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"10.1016\/j.jmii.2019.09.002_bib28","first-page":"556","article-title":"Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: real-world data","volume":"52","author":"Hong","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.jmii.2019.09.002_bib29","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jmii.2019.09.002_bib30","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3748\/wjg.v22.i4.1711","article-title":"Non-invasive assessment of liver fibrosis: between prediction\/prevention of outcomes and cost-effectiveness","volume":"22","author":"Stasi","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jmii.2019.09.002_bib31","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2019.09.002_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2019.09.002_bib33","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1111\/j.1572-0241.2002.05995.x","article-title":"Contribution of obesity to hepatitis C-related fibrosis progression","volume":"97","author":"Ortiz","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jmii.2019.09.002_bib34","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1053\/jhep.2001.24432","article-title":"Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity","volume":"33","author":"Adinolfi","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2019.09.002_bib35","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1053\/j.gastro.2003.11.056","article-title":"Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance","volume":"126","author":"Shintani","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jmii.2019.09.002_bib36","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00042737-200604000-00015","article-title":"Prevalence and factors associated with failure of liver stiffness measurement using FibroScan in a prospective study of 2114 examinations","volume":"18","author":"Foucher","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jmii.2019.09.002_bib37","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1002\/hep.23425","article-title":"Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations","volume":"51","author":"Castera","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jmii.2019.09.002_bib38","doi-asserted-by":"crossref","first-page":"e0206947","DOI":"10.1371\/journal.pone.0206947","article-title":"Comparison of FIB-4 and transient elastography in evaluating liver fibrosis of chronic hepatitis C subjects in community","volume":"13","author":"Cheng","year":"2018","journal-title":"PLoS One"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118219301380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118219301380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T13:24:25Z","timestamp":1761657865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118219301380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S1684118219301380"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2019.09.002","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subgroup analysis of the predictive ability of aspartate aminotransferase to platelet ratio index (APRI) and fibrosis-4 (FIB-4) for assessing hepatic fibrosis among patients with chronic hepatitis C","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2019.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}